Clinical Trials Search at Vanderbilt-Ingram Cancer Center
A Phase II Trial Evaluating Chemotherapy followed by Response-Based Reduced Radiation Therapy for Patients with Central Nervous System Germinomas
Not Available
II
Esbenshade, Adam
NCT06368817
COGACNS2321
An Open-label, Phase 1 Dose Escalation and Phase 2 Dose Expansion Study to Assess Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of SMP-3124LP in Adults with Advanced Solid Tumors
Not Available
I/II
Eng, Cathy
NCT06526819
VICC-DTPHI23348
A Randomized Phase III of Doxorubicin + Pembrolizumab Versus Doxorubicin Alone for the Treatment of Undifferentiated Pleomorphic Sarcoma (UPS) and Related Poorly Differentiated Sarcomas
Not Available
III
Davis, Elizabeth
NCT06422806
VICC-NTSAR24139
Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer
Not Available
I
Rosenthal, Eben
VICCHNP24602
A Randomized Phase III Study of BRAF-Targeted Therapy vs Cabozantinib in RAI-Refractory Differentiated Thyroid Cancer with BRAF V600Em
Not Available
III
Choe, Jennifer
NCT06475989
ECOGHNEA3231
ALTE2131 Triptorelin and Protection of Ovarian Reserve in Adolescents and Young Adults with Cancer an NCORP Phase 3 Study
Not Available
III
Davis, Elizabeth
NCT06513962
COGALTE2131
The CRYSTAL Study: CRYoablation Study for Outpatient Treatment of EArly-Stage Lung Cancer
Not Available
N/A
Maldonado, Fabien
NCT06593106
VICC-VCTHO24099
An International, Prospective, Open-label, Multi-Center, Randomized Phase III Study comparing Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) versus Observation to Delay Castration or Disease Recurrence in Adult Male Patients with Prostate-Specific Membrane Antigen (PSMA) Positive Oligometastatic Prostate Cancer (OMPC)
Not Available
III
Schaffer, Kerry
NCT05939414
VICC-DTURO23342
A Phase II Study of Cabozantinib for Patients with Recurrent or Progressive Meningioma
Not Available
II
Mohler, Alexander
NCT05425004
VICC-ITNEU23261
